Litigation Details for Prostrakan, Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2016)
✉ Email this page to a colleague
Prostrakan, Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-01-15 |
| Court | District Court, D. Delaware | Date Terminated | 2017-07-17 |
| Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 7,608,282 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Prostrakan, Inc. v. Actavis Laboratories UT, Inc.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for Prostrakan, Inc. v. Actavis Laboratories UT, Inc. (D. Del. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-01-14 | 3 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,608,282 B2; . (Bellew, Joseph…2016 17 July 2017 1:16-cv-00015 830 Patent Plaintiff District Court, D. Delaware | External link to document | |
| 2016-01-20 | 5 | S.a.r.l.). Date of Expiration of Patent: October 22, 2024 - 7,608,282.Thirty Month Stay Deadline: 6/4/… Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) …2016 17 July 2017 1:16-cv-00015 830 Patent Plaintiff District Court, D. Delaware | External link to document | |
| 2017-07-27 | 8 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,608,282 B2. (etg) (Entered:…2016 17 July 2017 1:16-cv-00015 830 Patent Plaintiff District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
